Webinar: Streamlined mRNA Synthesis for Increased Protein Expression

We are living in an exciting time for RNA as a therapeutic following the wide successes of 2 mRNA vaccines against SARS-CoV-2. mRNA, circRNA, or saRNA as platforms for medicine offer unique advantages over traditional medicines including speed, versatility, and expression profile. This talk by Jordana Henderson, Associate Director R&D, TriLink BioTechnologies, will review the design, manufacturing, and future technology options for synthesizing an RNA for therapeutic purposes. Proof of concept data using best-in-class streamlined mRNA manufacturing process will be shown to demonstrate benefits beyond turnaround time for drug substances.